Vol. 6, Issue 3 (2017)

Author(s):
Kseniia Ostrovska, Nataliia Ivanyshyn, Iryna Savelikhina, Oleksandr Varunkiv, Mariana Kulynych-Miskiv, Stepan Ornat, Galyna Korzh and Mykola Ostrovskyy

Abstract:
COPD is a serious chronic disease, which is increasingly being recognized as having an inflammatory component. New treatments are required that reduce inflammation and stop disease progression, and inhibition of PDE4 represents a promising mechanism to treat COPD, given the resulting effects on inflammation and associated underlying disease processes.